Credit Suisse analyst Jonathan Yong maintains Select Medical Hldgs (NYSE:SEM) with a Neutral and raises the price target from $29 to $32.
Credit Suisse Maintains Neutral on Select Medical Hldgs, Raises Price Target to $32
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.